Orphan Macrodomain Protein (human C6orf130) is an O-acyl-ADP-ribose Deacylase: Solution Structure and Catalytic Properties
Overview
Authors
Affiliations
Post-translational modification of proteins/histones by lysine acylation has profound effects on the physiological function of modified proteins. Deacylation by NAD(+)-dependent sirtuin reactions yields as a product O-acyl-ADP-ribose, which has been implicated as a signaling molecule in modulating cellular processes. Macrodomain-containing proteins are reported to bind NAD(+)-derived metabolites. Here, we describe the structure and function of an orphan macrodomain protein, human C6orf130. This unique 17-kDa protein is a stand-alone macrodomain protein that occupies a distinct branch in the phylogenic tree. We demonstrate that C6orf130 catalyzes the efficient deacylation of O-acetyl-ADP-ribose, O-propionyl-ADP-ribose, and O-butyryl-ADP-ribose to produce ADP-ribose (ADPr) and acetate, propionate, and butyrate, respectively. Using NMR spectroscopy, we solved the structure of C6orf130 in the presence and absence of ADPr. The structures showed a canonical fold with a deep ligand (ADPr)-binding cleft. Structural comparisons of apo-C6orf130 and the ADPr-C6orf130 complex revealed fluctuations of the β(5)-α(4) loop that covers the bound ADPr, suggesting that the β(5)-α(4) loop functions as a gate to sequester substrate and offer flexibility to accommodate alternative substrates. The ADPr-C6orf130 complex identified amino acid residues involved in substrate binding and suggested residues that function in catalysis. Site-specific mutagenesis and steady-state kinetic analyses revealed two critical catalytic residues, Ser-35 and Asp-125. We propose a catalytic mechanism for deacylation of O-acyl-ADP-ribose by C6orf130 and discuss the biological implications in the context of reversible protein acylation at lysine residues.
Insights into mechanisms of ubiquitin ADP-ribosylation reversal.
Zhang Z, Das C Biochem Soc Trans. 2024; 52(6):2525-2537.
PMID: 39584475 PMC: 11668277. DOI: 10.1042/BST20240896.
ADP-ribose hydrolases: biological functions and potential therapeutic targets.
Wang J, Wang Z, Zong W Expert Rev Mol Med. 2024; 26:e21.
PMID: 39375922 PMC: 11488344. DOI: 10.1017/erm.2024.17.
Mono-ADP-Ribosylation of Peptides: An Overview of Synthetic and Chemoenzymatic Methodologies.
Minnee H, Codee J, Filippov D Chembiochem. 2024; 25(24):e202400440.
PMID: 38984757 PMC: 11664928. DOI: 10.1002/cbic.202400440.
Ouyang F, Yuan P, Ju Y, Chen W, Peng Z, Xu H Front Endocrinol (Lausanne). 2024; 15:1340608.
PMID: 38699385 PMC: 11064697. DOI: 10.3389/fendo.2024.1340608.
PARP1: Liaison of Chromatin Remodeling and Transcription.
Zong W, Gong Y, Sun W, Li T, Wang Z Cancers (Basel). 2022; 14(17).
PMID: 36077699 PMC: 9454564. DOI: 10.3390/cancers14174162.